Tourmaline Bio
Brad Middlekauff is an experienced Chief Business Officer and General Counsel in the biotechnology industry, with a background in legal counsel, strategic planning, and business development. Their career spans across various companies in the biotech sector, including Nasdaq-listed companies and start-ups. Brad has been involved in developing antibody-based products for autoimmune diseases and cancer, as well as being a board member for a biotechnology company focused on immunotherapies. Brad Middlekauff also has experience in advisory roles at educational institutions such as Princeton University.
This person is not in any offices
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.